Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function

被引:73
|
作者
Wang, Fangjie [1 ]
Meng, Meng [1 ]
Mo, Banghui [1 ]
Yang, Yao [1 ]
Ji, Yan [1 ]
Huang, Pei [1 ]
Lai, Wenjing [1 ]
Pan, Xiaodong [1 ]
You, Tingting [1 ]
Luo, Hongqin [1 ]
Guan, Xiao [1 ]
Deng, Yafei [1 ]
Yuan, Shunzong [2 ]
Chu, Jianhong [3 ]
Namaka, Michael [1 ,4 ,5 ]
Hughes, Tiffany [6 ,7 ]
Ye, Lilin [8 ]
Yu, Jianhua [6 ,7 ,9 ]
Li, Xiaohui [1 ]
Deng, Youcai [1 ]
机构
[1] Army Med Univ Third Mil Med Univ, Coll Pharm, Inst Mat Med, 30 Gaotanyan Rd, Chongqing 400038, Peoples R China
[2] PLA 307 Hosp, Dept Lab Med, Dongdajie 8, Beijing 100071, Peoples R China
[3] Soochow Univ, Inst Blood & Marrow Transplantat, 199 Renai Rd, Suzhou 215123, Peoples R China
[4] Univ Manitoba, Rady Fac Hlth Sci, Coll Pharm, 750 McDermot Ave, Winnipeg, MB R3E 0T5, Canada
[5] Univ Manitoba, Rady Fac Hlth Sci, Coll Med, 750 McDermot Ave, Winnipeg, MB R3E 0T5, Canada
[6] Ohio State Univ, Ctr Comprehens Canc, 460 West 12th Ave,BRT 816, Columbus, OH 43210 USA
[7] James Canc Hosp, 460 West 12th Ave,BRT 816, Columbus, OH 43210 USA
[8] Army Med Univ Third Mil Med Univ, Inst Immunol, 30 Gaotanyan Rd, Chongqing 400038, Peoples R China
[9] Ohio State Univ, Div Hematol, Dept Internal Med, 460 West 12th Ave,BRT 816, Columbus, OH 43210 USA
来源
NATURE COMMUNICATIONS | 2018年 / 9卷
基金
中国国家自然科学基金;
关键词
NATURAL-KILLER-CELLS; IFN-GAMMA PRODUCTION; T-BET; LYMPHOID-CELLS; KINASE MTOR; ACTIVATION; IL-15; METABOLISM; IMMUNITY; DISEASE;
D O I
10.1038/s41467-018-07277-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The metabolic checkpoint kinase mechanistic/mammalian target of rapamycin (mTOR) regulates natural killer (NK) cell development and function, but the exact underlying mechanisms remain unclear. Here, we show, via conditional deletion of Raptor (mTORC1) or Rictor (mTORC2), that mTORC1 and mTORC2 promote NK cell maturation in a cooperative and non-redundant manner, mainly by controlling the expression of Tbx21 and Eomes. Intriguingly, mTORC1 and mTORC2 regulate cytolytic function in an opposing way, exhibiting promoting and inhibitory effects on the anti-tumor ability and metabolism, respectively. mTORC1 sustains mTORC2 activity by maintaining CD122-mediated IL-15 signaling, whereas mTORC2 represses mTORC1-modulated NK cell effector functions by restraining STAT5-mediated SLC7A5 expression. These positive and negative crosstalks between mTORC1 and mTORC2 signaling thus variegate the magnitudes and kinetics of NK cell activation, and help define a paradigm for the modulation of NK maturation and effector functions.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] The role of mTORC1 and mTORC2 in UVB-induced
    Lewis, Martha
    Shantz, Lisa
    FASEB JOURNAL, 2013, 27
  • [22] mTORC1 and mTORC2 as regulators of cell metabolism in immunity
    Linke, Monika
    Fritsch, Stephanie Deborah
    Sukhbaatar, Nyamdelger
    Hengstschlaeger, Markus
    Weichhart, Thomas
    FEBS LETTERS, 2017, 591 (19): : 3089 - 3103
  • [23] Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways
    Cho, Jin Hwa
    Kim, Kidae
    Kim, Sung Ah
    Park, Sungryul
    Park, Bi-Oh
    Kim, Jong-Hwan
    Kim, Seon-Young
    Kwon, Min Jee
    Han, Myeong Hoon
    Lee, Sung Bae
    Park, Byoung Chul
    Park, Sung Goo
    Kim, Jeong-Hoon
    Kim, Sunhong
    CELL DEATH AND DIFFERENTIATION, 2021, 28 (03): : 900 - 914
  • [24] Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways
    Jin Hwa Cho
    Kidae Kim
    Sung Ah Kim
    Sungryul Park
    Bi-Oh Park
    Jong-Hwan Kim
    Seon-Young Kim
    Min Jee Kwon
    Myeong Hoon Han
    Sung Bae Lee
    Byoung Chul Park
    Sung Goo Park
    Jeong-Hoon Kim
    Sunhong Kim
    Cell Death & Differentiation, 2021, 28 : 900 - 914
  • [25] mTORC1/mTORC2 signaling in pediatric low grade glioma and pilocytic astrocytoma.
    Shah, Smit
    Hutt, Marianne
    Karajannis, Matthias A.
    Raabe, Eric
    Eberhart, Charles G.
    Rodriguez, Fausto J.
    CANCER RESEARCH, 2013, 73 (08)
  • [26] Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma
    Jhanwar-Uniyal, Meena
    Dominguez, Jose F.
    Mohan, Avinash L.
    Tobias, Michael E.
    Gandhi, Chirag D.
    ADVANCES IN BIOLOGICAL REGULATION, 2022, 83
  • [27] Rapamycin Regulates Akt and ERK Phosphorylation Through mTORC1 and mTORC2 Signaling Pathways
    Chen, Xian-Guo
    Liu, Fei
    Song, Xing-Fu
    Wang, Zhi-Hua
    Dong, Zi-Qiang
    Hu, Zhi-Quan
    Lan, Ru-Zhu
    Guan, Wei
    Zhou, Tian-Gui
    Xu, Xiao-Ming
    Lei, Hong
    Ye, Zhang-Qun
    Peng, E-Jun
    Du, Li-Huan
    Zhuang, Qian-Yuan
    MOLECULAR CARCINOGENESIS, 2010, 49 (06) : 603 - 610
  • [28] Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
    Chen, Long
    Xu, Baoshan
    Liu, Lei
    Liu, Chunxiao
    Luo, Yan
    Chen, Xin
    Barzegar, Mansoureh
    Chung, Jun
    Huang, Shile
    ONCOTARGET, 2015, 6 (09) : 7136 - 7150
  • [29] Hyperactivity Following Loss of mTORC2 Signaling in the Dorsal Cortex: An mTORC1 Independent TSC Phenotype?
    Carson, R.
    Fu, C.
    Winzenburger, P.
    Ess, K.
    ANNALS OF NEUROLOGY, 2012, 72 : S173 - S173
  • [30] Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication
    Kuss-Duerkop, Sharon K.
    Wang, Juan
    Mena, Ignacio
    White, Kris
    Metreveli, Giorgi
    Sakthivel, Ramanavelan
    Metal, Miguel A.
    Munoz-Moreno, Raquel
    Chen, Xiang
    Krammer, Florian
    Diamonds, Michael S.
    Chen, Zhijian J.
    Garcia-Sastre, Adolfo
    Fontoura, Beatriz M. A.
    PLOS PATHOGENS, 2017, 13 (09)